However, previous research, as highlighted by Bhari et al., has linked high expression levels of both TERF1 and TERF2 to a poor prognosis in breast cancer, suggesting their potential as prognostic markers in cancer [25]. The gene discussed is TERF2; the disease is breast carcinoma.